Successful use of intrathecal daptomycin to treat meningitis due to vancomycin-resistant enterococcus faecium

Infectious Diseases in Clinical Practice

Volumn 20, Issue 6, 2012, Pages 416-418

  Kahler, Ralph C ^a   Holloway, Katherine ^b  

^a Hattiesburg Clinic   (United States)

^b CUBIST PHARMACEUTICALS INC   (United States)

Author keywords

daptomycin; Enterococcus faecium; intrathecal; intraventricular; meningitis; vancomycin resistant enterococci; ventriculitis

Indexed keywords

CREATINE KINASE; DAPTOMYCIN; GENTAMICIN; VANCOMYCIN;

ADULT; ANAMNESIS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MENINGITIS; BLOOD CULTURE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID SHUNTING; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG DOSE INCREASE; ENTEROCOCCUS FAECIUM; FEMALE; FEVER; HEADACHE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NAUSEA; PHYSICAL EXAMINATION; STAPHYLOCOCCUS HOMINIS; SUBARACHNOID HEMORRHAGE; SUBDURAL HEMATOMA; SYMPTOM; TREATMENT INDICATION; TREATMENT OUTCOME; UNCONSCIOUSNESS; VANCOMYCIN RESISTANT ENTEROCOCCUS; VOMITING;

EID: 84870255893     PISSN: 10569103     EISSN: 15369943     Source Type: Journal    
DOI: 10.1097/IPC.0b013e3182506d8f     Document Type: Article

References (18)

1. Elvy J, Porter D, Brown E. Treatment of external ventricular drain-associated ventriculitis caused by Enterococcus faecalis with intraventricular daptomycin. J Antimicrob Chemother. 2008;61:461-462.
2. Lo CH, Spelman D, Bailey M, et al. External ventricular drain infections are independent of drain duration: an argument against elective revision. J Neurosurg. 2007;106:378-383.
3. McClelland S III, Hall WA. Postoperative central nervous system infection: incidence and associated factors in 2111 neurosurgical procedures. Clin Infect Dis. 2007;45:55-59.
4. Morris A, Low DE. Nosocomial bacterial meningitis, including central nervous system shunt infections. Infect Dis Clin North Am. 1999;13:735-750.
5. Low DE, Keller N, Barth A, et al. Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis. 2001;32(suppl 2):S133-S145.
6. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39:1267-1284.
7. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin- resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52:1-38.
8. Cubicin\Prescribing Information [Cubicin\website]. November, 2010. Available at: http://www.cubicin.com/pdf/PrescribingInformation.pdf. Accessed April 7, 2011.
9. Grandgirard D, Schürch C, Cottagnoud P, et al. Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis. Antimicrob Agents Chemother. 2007;51:2173-2178.
10. Gerber P, Stucki A, Acosta F, et al. Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis. J Antimicrob Chemother. 2006;57:720-723.
11. Riser MS, Bland CM, Rudisill CN, et al. Cerebrospinal fluid penetration of high-dose daptomycin in suspected Staphylococcus aureus meningitis. Ann Pharmacother. 2010;44:1832-1835.
12. Bookstaver PB, Rudisill CN, Hashem M, et al. Successful treatment of vancomycin-resistant Enterococcus faecium meningitis with high-dose daptomycin. Pharmacotherapy. 2009;29(10):217e-218e. Abstract.
13. Kullar R, Chin JN, Parker D, et al. Central nervous system (CNS) penetration and pharmacokinetics (PK) of daptomycin (DAP). 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 12-15, 2010, Boston, MA 2010.
14. English BK, Maryniw EM, Talati AJ, et al. Diminished macrophage inflammatory response to Staphylococcus aureus isolates exposed to daptomycin versus vancomycin or oxacillin. Antimicrob Agents Chemother. 2006;50:2225-2227.
15. Cottagnoud P, Pfister M, Acosta F, et al. Daptomycin is highly efficacious against penicillin-resistant and penicillin-and quinolone-resistant pneumococci in experimental meningitis. Antimicrob Agents Chemother. 2004;48:3928-3933.
16. Zyvox\ Prescribing Information [Zyvox\ website]. June, 2010. Available at: http://www.pfizer.com/files/products/uspi-zyvox.pdf. Accessed April 7, 2011.
17. Sader HS, Moet GJ, Farrell DJ, et al. Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010). Diagn Microbiol Infect Dis. 2011;70:412-416.
18. Jaspan HB, Brothers AW, Campbell AJ, et al. Multidrug-resistant Enterococcus faecium meningitis in a toddler: characterization of the organism and successful treatment with intraventricular daptomycin and intravenous tigecycline. Pediatr Infect Dis J. 2010;29:379-381.